COVID-19 patients respond to Gilead's experimental drug remdesivir, says report
4 years, 8 months ago

COVID-19 patients respond to Gilead's experimental drug remdesivir, says report

India TV News  

Patients infected with the coronavirus are responding to remdesivir, an experimental drug of Gilead Sciences, news agency Reuters quoted a report as saying. Citing medical news website STAT, a University of Chicago hospital participating in a study of the antiviral medication said it is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged from the hospital in less than a week. The University of Chicago is one of the 152 locations participating in Gilead's trial for severe COVID-19 patients. Last week, the New England Journal of Medicine indicated that over two-thirds of a small group of severely ill coronavirus patients saw their condition improve after treatment with remdesivir.

Patients Gilead  saying  remdesivir  drug  coronavirus  trial  covid19  patients  experimental  study  severe  symptoms  respond  report  university  gileads  week

History of this topic

Gilead Put Lives before Profits! Says AHF INDIA
1 year, 6 months ago

Gilead Put Lives before Profits! Says AHF INDIA

Deccan Chronicle  

Gilead Sciences Inc. is among the top 15 largest biopharmaceutical firms in the world, generating over $27 billion in revenue and paying its CEO over $19 million in 2021 alone. AHF - AIDS HEALTHCARE FOUNDATION, continues pressuring, pharmaceutical giant Gilead Sciences to stop its greedy tactics and put lives before profits, Gilead is one of the worst offenders of big …

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans
1 year, 11 months ago

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

LA Times  

A two-shot dose of Evusheld at a University of Washington Medicine clinic in Seattle. For her patients, she said, “it was kind of like being told the seat belts in your car won’t work anymore, and we’re not going to be able to replace them with anything.” In recent months, nine new subvariants of the dominant Omicron strain have proven …

Why Remdesivir’s Manufacturing Licence was Not Given to Pharma PSUs When People Were Battling Second Wave: Parl Panel
2 years, 9 months ago

Why Remdesivir’s Manufacturing Licence was Not Given to Pharma PSUs When People Were Battling Second Wave: Parl Panel

News 18  

Why none of the pharmaceutical public sector units were not granted a licence to produce Remdesivir when the common man was facing “hardships” in procuring the anti-Covid drug during the second wave, the parliamentary standing committee on chemicals and fertilizers has made an observation in its report. “However, the committee failed to understand that none of the Pharma Public Sector …

'Prepare for new COVID-19 variants': Joe Biden tells pandemic-weary Americans
2 years, 10 months ago

'Prepare for new COVID-19 variants': Joe Biden tells pandemic-weary Americans

Firstpost  

In his first State of the Union Address on Tuesday, Biden said thanks to the progress the country has made last year, COVID-19 need no longer controls the lives of the Americans. President Joe Biden has urged Americans to prepare themselves for new coronavirus variants as he launched a new initiative aimed at helping COVID-19-infected people to get tested at …

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works
2 years, 11 months ago

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works

News 18  

It was dinner time when she called for help. They don’t want to use it, but keep it.” Much before the outbreak of second wave, in November 2020, the World Health Organization issued a conditional recommendation against the use of Remdesivir in hospitalised patients, regardless of disease severity saying “there is currently no evidence that Remdesivir improves survival and other …

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment
2 years, 11 months ago

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment

News 18  

India has cut down on the use of the experimental drug Remdesivir and immunosuppressive drug Tocilizumab for the treatment of Covid-19. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with Covid-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the overuse of steroids, the protocol for …

WHO adds new drugs to COVID treatments amid Omicron surge
2 years, 11 months ago

WHO adds new drugs to COVID treatments amid Omicron surge

Al Jazeera  

Latest recommendations prompt new calls for patent waivers to allow more people access to treatments. The drug baricitinib, which is also used to treat rheumatoid arthritis, is “strongly recommended” for patients with severe or critical COVID-19, in combination with corticosteroids, the UN agency’s panel of international experts said in the guidelines which were published by the British Medical Journal on …

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment
3 years ago

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment

The Hindu  

If full vaccination using any COVID-19 vaccine greatly reduces a person’s risk of progressing to severe disease and death, then the move by the U.S. FDA to grant emergency-use authorisation to two oral antiviral drugs for certain categories of people who are likely to become severely ill provides a much-needed fillip to fight the disease. Unlike in the case of …

Merck’s COVID pill shows lower efficacy in updated study
3 years, 1 month ago

Merck’s COVID pill shows lower efficacy in updated study

Al Jazeera  

Drugmaker says final analysis of trial results showed molnupiravir led to 30 percent reduction in hospitalisations and deaths, compared with about 50 percent in interim study. Drugmaker Merck’s experimental COVID-19 pill is significantly less effective in slashing hospitalisations and deaths than previously reported, the company has said, following the release of a full analysis of trial results. The United States-based …

EU regulator recommends Merck’s COVID-19 pill for emergency use
3 years, 1 month ago

EU regulator recommends Merck’s COVID-19 pill for emergency use

Al Jazeera  

The European Union’s medicines watchdog has advised its member states they can use a potentially groundbreaking COVID-19 antiviral pill in emergency situations triggered by soaring infection rates, ahead of the treatment’s formal approval across the bloc. Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not …

Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 2 months ago

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Associated Press  

WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on …

UK approves Merck’s antiviral COVID-19 pill in world first move
3 years, 2 months ago

UK approves Merck’s antiviral COVID-19 pill in world first move

Al Jazeera  

Merck’s molnupiravir to be given to recently-infected COVID-19 patients twice a day, for five days. The United Kingdom has become the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Merck’s molnupiravir has been closely watched since data last month showed it could halve the chances of dying or …

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19
3 years, 2 months ago

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19

CNN  

CNN — The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. The companies have sought US Food and Drug Administration emergency use authorization for the drug, and the FDA said it will convene its Antimicrobial Drugs Advisory Committee …

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist
3 years, 3 months ago

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist

NL Times  

Pharmaceutical company Merck announced last week that its antiviral medicine Molnupiravir could prevent 50 percent of coronavirus-related hospital admissions and deaths in high-risk groups if administered in time. According to virologists, this new treatment is a "welcome addition," but not a "miracle cure," they said to NOS. According to him, especially oral administration is "a welcome addition" to the treatment …

EXPLAINED: A Pill You Can Pop At Home To Beat Covid. Here's Why Merck's Antiviral Drug Is Raising Hopes
3 years, 3 months ago

EXPLAINED: A Pill You Can Pop At Home To Beat Covid. Here's Why Merck's Antiviral Drug Is Raising Hopes

News 18  

The global death toll from Covid-19 is said to now have crossed 5 million even as the pandemic’s end is yet to appear within sight. Merck, which has partnered the US-based Ridgeback Biotherapeutics for the development of the drug, said that Phase-3 trials showed that it “significantly reduced the risk of hospitalisation or death… in at risk, non-hospitalised adult patients …

Explained | Molnupiravir, Merck’s new drug to treat COVID-19
3 years, 3 months ago

Explained | Molnupiravir, Merck’s new drug to treat COVID-19

The Hindu  

Why is there much excitement about molnupiravir, the investigational new drug for COVID-19? Pharmaceutical major Merck and Ridgeback Biotherapeutics announced via a press release on October 1 the early results from Phase-3 trials that its anti-viral drug molnupiravir halved the chances of hospitalisation in COVID-19 patients with mild or moderate disease. Several noted clinicians have said that these are promising …

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?
3 years, 3 months ago

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?

CNN  

CNN — Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19. But Merck says it will seek authorization from the US Food and Drug Administration, and if it’s granted, the drug could be the first antiviral treatment available orally to fight Covid-19. …

New drug combination found effective against coronavirus infection: Study
3 years, 3 months ago

New drug combination found effective against coronavirus infection: Study

Deccan Chronicle  

London: A new drug combination can suppress infection by the SARS-CoV-2 virus, which causes COVID-19, according to a study conducted in animals and cell cultures. "This combination effectively suppresses the infection, said Denis Kainov, a professor at the Norwegian University of Science and Technology's. "SARS-CoV-2 and its vaccine/immune-escaping variants continue to pose a serious threat to public health due to …

Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by half
3 years, 3 months ago

Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by half

LA Times  

Drugmaker Merck says its experimental COVID-19 pill reduced hospitalizations and deaths by half in newly infected people. Drugmaker Merck said Friday that its experimental antiviral pill cuts rates of severe disease and death in half for newly diagnosed COVID-19 patients at high risk of becoming seriously ill. Health experts from Dr. Anthony Fauci on down have long called for a …

Covid pill works against all variants including Delta, manufacturer says
3 years, 3 months ago

Covid pill works against all variants including Delta, manufacturer says

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Drugmaker Merck & Co’s experimental …

Regeneron: Covid-19 antibody treatments work, but they’re ‘not the path out of this pandemic’
3 years, 4 months ago

Regeneron: Covid-19 antibody treatments work, but they’re ‘not the path out of this pandemic’

CNN  

CNN — When Texas Gov. Monoclonal antibodies such as those made by Regeneron and GlaxoSmithKline won’t work for every Covid-19 patient; mAbs, as they are known, are only available for people age 12 and older and who aren’t hospitalized or severely ill. Regeneron’s therapy can also be used for some people who know they were exposed to the virus,but don’t …

WHO Tests 3 Drugs for Treating Coronavirus Infection
3 years, 4 months ago

WHO Tests 3 Drugs for Treating Coronavirus Infection

News 18  

The World Health Organization says it will soon test three drugs used for other diseases to see if they might help patients sickened by the coronavirus. In a statement on Wednesday, the U.N. health agency says the three drugs would be adopted into the next phase of its ongoing global research into identifying potential treatments for COVID-19. The drugs were …

Vaccines are terrific, but where are the COVID-19 treatments?
3 years, 6 months ago

Vaccines are terrific, but where are the COVID-19 treatments?

LA Times  

Since the early days of the pandemic, we’ve all wanted to know when and how it will end. That research has yielded three authorized vaccines — so far — that are highly effective not just against the original virus but also against its many variants, including the highly transmissible Delta variant. Mehta spoke to The Times about which medicines are …

US to spend $3.2B on treatments for COVID-19, other viruses
3 years, 6 months ago

US to spend $3.2B on treatments for COVID-19, other viruses

Associated Press  

WASHINGTON — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics. The new program will invest in “accelerating things that are already in progress” for COVID-19 but also would work to come up with treatments for other viruses, said Dr. Anthony Fauci, the nation’s …

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19
3 years, 6 months ago

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19

Daily Mail  

The Biden administration is devoting $3.2 billion to help develop antiviral pills to treat COVID-19, officials said on Thursday. The U.S. government has committed $3.2 billion to help develop antiviral pills to treat COVID-19, officials including Dr Anthony Fauci announced on Thursday Several pills are in development that will be used to minimize symptoms of the virus early on in …

U.S. to spend $3.2 billion on treatments for COVID-19 and other viral diseases
3 years, 6 months ago

U.S. to spend $3.2 billion on treatments for COVID-19 and other viral diseases

LA Times  

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks May 11 at a hearing on Capitol Hill. The new program will invest in “accelerating things that are already in progress” for COVID-19 but also would work to come up with treatments for other viral conditions, said Dr. Anthony Fauci, the nation’s top infectious disease expert. …

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab
3 years, 7 months ago

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab

Firstpost  

Among the drugs and treatment methods that have been removed from the recommendations are Ivermectin, Azithromycin and plasma therapy The Union health ministry has issued guidelines on management of COVID-19 patients, dropping many drugs which have been widely used for treatment until now. While Remdesivir has been granted Emergency Use Authorisation, Tocilizumab has been approved for off-label use only FOLLOW …

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment
3 years, 7 months ago

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment

News 18  

The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care. To stop the misuse of Remdesivir, the government further recommended that if the drug is to be advised or ordered during odd hours, it should be done …

Coronavirus | Centre books 30 crore doses of new vaccine
3 years, 7 months ago

Coronavirus | Centre books 30 crore doses of new vaccine

The Hindu  

The Health Ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore COVID-19 vaccine doses. “The proposal of M/s Biological-E was examined and recommended for approval after due diligence by National Expert Group on Vaccine Administration for COVID-19,” the Ministry said. It added that the arrangement with the manufacturer is part of the wider endeavour of the …

No evidence of Remdesivir's effectiveness, might be dropped as COVID-19 treatment: Dr DS Rana
3 years, 7 months ago

No evidence of Remdesivir's effectiveness, might be dropped as COVID-19 treatment: Dr DS Rana

Firstpost  

Ganga Ram hospital Chairperson Dr DS Rana said, “Medicines that do not have any activity to work, will have to be discontinued.” Ganga Ram hospital Chairperson Dr DS Rana on Tuesday said that Remdesivir is also being considered to be dropped from COVID-19 treatment soon as there is no evidence of its effectiveness in treating COVID-19 patients. While talking to …

Does India's trial and error approach to fighting mutating coronavirus need course correction?
3 years, 7 months ago

Does India's trial and error approach to fighting mutating coronavirus need course correction?

India Today  

The second wave continues to wreak havoc in India with over 4,500 deaths recorded in a day on Wednesday. The Indian Council of Medical Research decision came within days of a study published in The Lancet that suggested plasma therapy did not improve survival or other pre-specified clinical outcomes in patients. Interestingly, similar data from ICMR's own trials was released …

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium
3 years, 7 months ago

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium

The Quint  

Chief Minister MK Stalin recently announced that the government will open Remdesivir counters at Madurai, Coimbatore, Trichy and Tirunelveli to address the state-wide shortage of the anti viral drug. In its submissions to the Madras HC, the state government added that it had received 250,000 vials of Remdesivir so far and the minimum requirement in the state was 20,000 vials …

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?
3 years, 7 months ago

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?

India TV News  

During COVID 19 second wave in India, a number of people are seen hunting for oxygen cylinders, ICU beds and many more medical facilities across the country. Know all about it here: According to an infographic video shared by PIB fact check, a verified Twitter account by the government of India to counter misinformation on govt. Meanwhile, India recorded 362,727 …

When to use Remdesivir, Ivermectin? India's Covid treatment protocol and what experts say
3 years, 7 months ago

When to use Remdesivir, Ivermectin? India's Covid treatment protocol and what experts say

India Today  

As the second wave of Covid-19 wreaks havoc across the country, the spotlight is on what India has recommended and what it hasn't for the management of adult patients. A look at India’s clinical management protocol: Covid treatment protocol for people with mild disease In the case of mild infection, upper respiratory tract symptoms like fever without shortness of breath …

Coronavirus breakthrough in Amsterdam could reduce ICU admissions
3 years, 7 months ago

Coronavirus breakthrough in Amsterdam could reduce ICU admissions

Dutch News  

Scientists in Amsterdam say they have solved one of the most vexing puzzles of Covid-19: why some patients deteriorate rapidly just as the virus seems to be on the wane. The team at the UMC teaching hospital found that while the majority of hospital patients recover, a few produce excessive numbers of antibodies, causing potentially fatal inflammation of the lungs. …

Coronavirus breakthrough in Amsterdam could reduce ICU admissions
3 years, 7 months ago

Coronavirus breakthrough in Amsterdam could reduce ICU admissions

Dutch News  

Scientists in Amsterdam say they have solved one of the most vexing puzzles of Covid-19: why some patients deteriorate rapidly just as the virus seems to be on the wane. The team at the UMC teaching hospital found that while the majority of hospital patients recover, a few produce excessive numbers of antibodies, causing potentially fatal inflammation of the lungs. …

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us
3 years, 8 months ago

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us

News 18  

Soon after the start of the second wave of COVID-19 pandemic in India, the images of people standing in long queues outside the chemist stores/pharmacies across India, were all over the newspapers. Though clinical trials have not found Remdesivir beneficial in COVID-19 treatment; however, clinicians in India and even the national COVID-19 task force and expert groups in India continue …

Doctors divided over use but scramble for Remdesivir continues
3 years, 8 months ago

Doctors divided over use but scramble for Remdesivir continues

The Hindu  

The scramble for Remdesivir, the anti-viral drug used in COVID-19 management, is increasing by the day even as doctors are divided on its use. Private Hospitals and Nursing Homes Association president H.M. Prasanna said that the helpline set up by the government is of little use. Manjunath, nodal officer for labs and testing in the State’s COVID-19 task force, said …

American biopharmaceutical company Gilead announces steps to expand Remdesivir availability in India
3 years, 8 months ago

American biopharmaceutical company Gilead announces steps to expand Remdesivir availability in India

India TV News  

American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India. "The recent surge of COVID-19 cases in India is having a devastating impact on communities and has created unprecedented pressure on health systems," Johanna Mercier, the chief commercial officer of Gilead Sciences said on …

Russian firm awaits government approval to ship remdesivir to India
3 years, 8 months ago

Russian firm awaits government approval to ship remdesivir to India

India Today  

Russian pharmaceutical firm Pharmasyntez said on Monday it was ready to ship up to 1 million packs of the remdesivir antiviral drug to India by end-May to help fight a surge in Covid-19 cases there, once it has received the approval of Russia's government. The move comes soon after the drug's patent holder, US firm Gilead Sciences, filed a lawsuit …

Coronavirus | Biological E gets nod to start Phase III trials of COVID-19 vaccine
3 years, 8 months ago

Coronavirus | Biological E gets nod to start Phase III trials of COVID-19 vaccine

The Hindu  

Pharmaceuticals and biologics firm Biological E has received approval to start Phase III clinical trial of its COVID-19 subunit vaccine candidate from a Subject Expert Committee of the Central Drugs Standard Control Organization. According to Biological E, the Phase I/II clinical trial evaluated safety and immunogenicity of the vaccine candidate in about 360 healthy subjects aged 18-65 years. We believe …

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19
3 years, 8 months ago

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19

News 18  

The Indian Council of Medical Research on Tuesday shared some suggestions for rational and safe use of Remdesivir in Covid-19 as the demand for the medicine has increased for treating coronavirus patients especially in Covid-hit states including Maharashtra, Delhi, Karnataka and others. Remdesivir is one of the investigational drugs approved for emergency use in treating hospitalized Covid-19 patients. Suggestion for …

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria
3 years, 8 months ago

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria

News 18  

Amid a steep spike in COVID-19 cases leading to increased demand for medicines for treating coronavirus, top health experts in the government on Monday said anti-viral drug remdesivir is "not a magic bullet" and does not reduce mortality. Addressing the media, AIIMS Director Dr Randeep Guleria said remdesivir should only be given to patients hospitalised with moderate illness, who had …

Amid Covid Spurt, Medicos Advice People To Use Remdesivir Judiciously and Only in a Hospital Setting
3 years, 8 months ago

Amid Covid Spurt, Medicos Advice People To Use Remdesivir Judiciously and Only in a Hospital Setting

News 18  

Amid a fight to acquire Remdesivir for ailing Covid-19 patients, a group of medical experts, professionals, and task-forces have stated that the injection can only be used inside a hospital setting. Maharashtra’s Covid-19 Task Force member Dr. Shashank Joshi took to Twitter to put out a statement saying that Remdesivir is not a ‘life-saving’ drug. The statement also made it …

Why Indian doctors prescribe Remdesivir for Covid-19 despite negative global medical view
3 years, 8 months ago

Why Indian doctors prescribe Remdesivir for Covid-19 despite negative global medical view

India Today  

While a cacophony has broken out over the shortage of Remdesivir injections across the country, international health experts are wondering why it is so widely being prescribed in India. Dr Aviral Vatsa of the National Health Services Scotland said, “The UK guidelines, the Stanford US guidelines or even WHO guidelines have clearly said that there is no clear evidence any …

When Do You Really Need Remdesivir? Does It Work?
3 years, 8 months ago

When Do You Really Need Remdesivir? Does It Work?

The Quint  

Let’s go back to the basics. Remdesivir is an antiviral drug developed by American pharmaceutical giant Gilead Sciences. It was made to treat Hepatitis C and respiratory syncytial viruses over a decade ago, but it never got marketing approval. COVID-19 brought the drug back into the picture – and US President Trump offered Remdesivir to UK Prime Minister Boris Johnson, …

Remdesivir: What is it and why is it being black marketed? All you need to know
3 years, 8 months ago

Remdesivir: What is it and why is it being black marketed? All you need to know

Op India  

In the last month, India went from reporting around 25,000+ Covid-19 cases to 1,85,000+ cases. In May 2020, the US Food and Drug Administration issued an emergency use authorisation for Remdesivir for the treatment of Covid-19 in adults and children hospitalised with severe disease. It may also help to conserve scarce health care resources, such as ventilators, during this pandemic.” …

Yogi Adityanath directs UP health department to urgently acquire Remdesivir injections from Ahmedabad
3 years, 8 months ago

Yogi Adityanath directs UP health department to urgently acquire Remdesivir injections from Ahmedabad

India TV News  

Amid a shortage of Remdesivir in Uttar Pradesh, Chief Minister Yogi Adityanath has directed the state health department to acquire 25,000 injections of Remdesivir from Gujarat's Ahmedabad on an urgent basis. In view of the sudden spike in demand due to the surge in COVID-19 cases, India has also banned the export of Remdesivir and Remdesivir Active Pharmaceutical Ingredients till …

Remdesivir Explained: What is the repurposed Covid-19 drug, why is there a shortage, do you need it?
3 years, 8 months ago

Remdesivir Explained: What is the repurposed Covid-19 drug, why is there a shortage, do you need it?

India Today  

Remdesivir, an injectable anti-viral drug repurposed for Covid-19 treatment, has been flying off the shelves of pharmacies over the last few weeks ever since India began reporting a steep rise in cases of the novel coronavirus. Remdesivir, which was cleared by the country's top drug regulator for restricted use in an emergency situation in June 2020, is being used in …

No evidence of Remdesivir's effectiveness in treating Covid patients: WHO
3 years, 8 months ago

No evidence of Remdesivir's effectiveness in treating Covid patients: WHO

India Today  

Amid the surge in demand for antiviral drug Remdesivir, the World Health Organization has said that there is still no evidence to suggest that the drug is useful in treating hospitalised Covid-19 patients. WHO's Chief Scientist Dr Soumya Swaminathan and its Technical Lead on Covid, Dr Maria Van Kerkhove on Monday told India Today TV that results from five clinical …

Discover Related